Bicocca Open Archive

Logo unimib boa
BIAGI, ETTORE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.953
EU - Europa 3.383
AS - Asia 1.336
SA - Sud America 22
Continente sconosciuto - Info sul continente non disponibili 13
AF - Africa 7
OC - Oceania 7
Totale 14.721
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.801
SE - Svezia 676
CN - Cina 577
DE - Germania 530
UA - Ucraina 465
IE - Irlanda 463
IT - Italia 396
SG - Singapore 343
RU - Federazione Russa 265
GB - Regno Unito 198
HK - Hong Kong 187
CA - Canada 145
FI - Finlandia 114
VN - Vietnam 92
FR - Francia 58
TR - Turchia 52
BE - Belgio 44
IN - India 44
AT - Austria 42
DK - Danimarca 37
NL - Olanda 35
BG - Bulgaria 20
BR - Brasile 13
JP - Giappone 13
EU - Europa 10
IR - Iran 10
RO - Romania 9
ID - Indonesia 8
CH - Svizzera 7
ES - Italia 7
MX - Messico 6
AU - Australia 5
KR - Corea 5
MU - Mauritius 4
CL - Cile 3
CZ - Repubblica Ceca 3
IL - Israele 3
PL - Polonia 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CO - Colombia 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
A1 - Anonimo 1
AL - Albania 1
AR - Argentina 1
BO - Bolivia 1
BY - Bielorussia 1
EC - Ecuador 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
LK - Sri Lanka 1
MD - Moldavia 1
MY - Malesia 1
PR - Porto Rico 1
PT - Portogallo 1
SI - Slovenia 1
Totale 14.721
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.605
Woodbridge 1.238
Fairfield 876
Houston 810
Chandler 724
Wilmington 691
Ashburn 539
Jacksonville 516
Dublin 454
Seattle 373
Cambridge 335
Frankfurt am Main 326
Dearborn 316
Singapore 260
Princeton 194
Hong Kong 184
New York 173
Nanjing 133
Milan 113
Lawrence 85
Lachine 83
Shanghai 81
Beijing 69
Altamura 68
Santa Clara 61
Dong Ket 60
San Diego 47
Brussels 42
Vienna 41
Nanchang 38
Boardman 35
Andover 33
Lissone 33
Toronto 33
Tianjin 31
Fremont 30
Helsinki 29
Hebei 27
Mountain View 26
Shenyang 26
Huizen 23
Hangzhou 20
Plovdiv 20
Guangzhou 18
Jinan 18
Changsha 17
Los Angeles 17
Ningbo 16
Jiaxing 15
Falls Church 14
Kocaeli 14
Nürnberg 14
Ottawa 14
Auburn Hills 13
London 13
University Park 13
Dallas 12
Edmonton 12
Norwalk 12
Rome 12
Zhengzhou 12
Philadelphia 11
Chicago 10
Taizhou 9
Contursi 8
Detroit 8
Kunming 8
Washington 8
Hefei 7
Jakarta 7
Munich 7
Redmond 7
São Paulo 7
Brooklyn 6
Monza 6
Moscow 6
Brescia 5
Madrid 5
San Mateo 5
Tappahannock 5
Cuauhtémoc 4
Florence 4
Hanoi 4
Missaglia 4
Napoli 4
Padova 4
Amsterdam 3
Bergamo 3
Bonndorf 3
Brno 3
Cardano al Campo 3
Central 3
Cerreto Guidi 3
Changchun 3
Chengdu 3
Clearwater 3
Como 3
Daejeon 3
Desio 3
Genova 3
Totale 11.358
Salva come PNG Salva come JPEG
Nome #
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 316
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 293
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 286
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories 275
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 258
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 253
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy 240
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 237
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 234
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 233
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 232
T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy 227
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia 225
GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease 216
Immunotherapy of acute leukemia by chimeric antigen receptormodified lymphocytes using an improved Sleeping Beauty transposon platform 214
Interleukin-17-producing t-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation 213
Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy 207
Stable Expression Of Chimeric Antigen Receptors (CARs) By Sleeping Beauty-Mediated Gene Transfer and Efficient Expansion Of Leukemia-Specific Cytokine-Induced Killer (CIK) Cells 202
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 198
Exploration of the lysis mechanisms of leukaemic blasts by chimaeric T-cells 195
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: A phase I study 194
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation 193
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 193
Molecular transfer of CD40 and OX40 ligands to leukemic human B cells induces expansion of autologous tumor-reactive cytotoxic T lymphocytes 187
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 187
Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. 186
Chimeric T-cell receptors: New challenges for targeted immunotherapy in hematologic malignancies 184
Long-term effects of bone marrow transplantation on dental status in children with leukaemia 183
Acute myeloid leukemia and novel biological treatments: Monoclonal antibodies and cell-based gene-modified immune effectors 182
Characterization of Plated Lysate Cultured Mesenchymal Stromal Cells and Their Potential Use in Tissue-Engineered Osteogenic Devices for the Treatment of Bone Defects 176
Upregulation of Adhesion Molecules on Leukemia Targets Improves the Efficacy of Cytotoxic T Cells Transduced With Chimeric Anti-CD19 Receptor 175
Chimeric Antigen Receptors against CD33/CD123 antigens efficiently target primary Acute Myeloid Leukemia cells in vivo 172
Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine 168
Antigen-induced regulatory T cells 167
TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission 167
Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia 165
Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives 163
Comparison of different suicide-gene strategies for the safety improvement of genetically manipulated T cells 162
GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy 162
Characterization of migratory activity and cytokine profile of helper and cytotoxic CMV-specific T-cell lines expanded by a selective peptide library 161
Targeting of Acute Myeloid Leukemia by Cytokine-Induced Killer Cells Redirected with a Novel CD123-Specific Chimeric Antigen Receptor 160
Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells 159
Bath PUVA therapy in pediatric patients with drug-resistant cutaneous graft-versus-host disease 159
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor 158
Donor-derived CD19-targeted T cells in allogeneic transplants 158
Febrile complications in the first 100 days after bone marrow transplantation in children: a single center's experience 157
Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosis 157
Bystander transfer of functional human CD40 ligand from gene-modified fibroblasts to B-chronic lymphocytic leukemia cells 156
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient 155
CD40 activation of BCP-ALL cells generates 11L-10-producing, 11L-12-defective APCs that induce allogeneic T-cell anergy 152
Isolation of monocytes from leukapheretic products for large-scale GMP-grade generation of cytomegalovirus-specific T-cell lines by means of an automated elutriation device 152
Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia 152
Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes 151
Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation. 148
Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with crohn's disease 148
A life-threatening paediatric case of acute autoimmune haemolytic anaemia (AIHA) successfully cured by plasma-exchange and combined immunosuppressive treatment 147
Chimeric Antigen Receptor for Specific Targeting of Acute Myeloid Leukemia 147
Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia 147
Role of early diagnosis for a noninvasive treatment of pulmonary thromboembolism in leukemic children 143
Cytokine Induced Killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors 141
Intrathecal chemotherapy with antineoplastic agents in children 141
Mechanical and infective central venous catheter-related complications: a prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies 137
PTX3 as a potential novel tool for the diagnosis and monitoring of pulmonary fungal infections in immuno-compromised pediatric patients. 136
Estudio experimental sobre la utilización de células madre humanas en la terapia de los defectos periodontales: resultados preliminares 136
Efficient lentiviral transduction of primary human acute myelogenous and lymphoblastic leukemia cells 134
Development of an alveolar bone regeneration protocol with mesenchyl stem cells for the therapy of severe bone resorption in periodontal disease 133
Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis 133
A persistent severe autoimmune hemolytic anemia despite apparent direct antiglobulin test negativization 132
Cell-based strategies to manage leukemia relapse: Efficacy and feasibility of immunotherapy approaches 132
Prolonged extracorporeal membrane oxygenation therapy for severe acute respiratory distress syndrome in a child affected by rituximab-resistant autoimmune hemolytic anemia: A case report 130
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia 129
T lymphocytes redirected against the κ light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells 125
Immunosuppression does not affect human bone marrow mesenchymal stromal cell efficacy after transplantation in traumatized mice brain 125
From Bone Marrow Transplantation to Cellular Therapies: Possible therapeutic strategies in managing autoimmune disorders 125
Effectiveness of extracorporeal photochemotherapy in treating long-term refractory chronic graft-versus-host disease 124
Basic biology and clinical application of multipotent mesenchymal stromal cells: from bench to bedside 123
In Vitro Comparison of Three Different Chimeric Receptor-modified Effector T-cell Populations for Leukemia Cell Therapy 113
New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future 113
CD40 ligand-stimulated B cell precursor leukemic cells elicit interferon-gamma production by autologous bone marrow T cells in childhood acute lymphoblastic leukemia 113
The washouts of discarded bone marrow collection bags and filters are a very abundant source of hMSCs 109
In Vitro and In Vivo Antitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL against CD33 Acute Myeloid Leukemia 106
Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression. Mol Cancer 105
LONG TERM SURVIVAL AND EFFICACY OF HUMAN BONE MARROW MESENCHYMAL STEM CELLS IN TRAUMATIZED MICE BRAIN IS NOT DEPENDENT ON IMMUNOSUPPRESSIVE TREATMENT. 104
Phase I Trial of Vaccination With Autologous Neuroblastoma Tumor Cells Genetically Modified to Secrete IL-2 and Lymphotactin 102
In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor 100
Long term efficacy of human bone marrow mesenchymal stem cells in traumatized mice brain is not affected by immunosuppressive treatment 97
A Phase 1/2 Study of Autologous Neuroblastoma Tumor Cells Genetically Modified to Secrete IL-2 in Patients With High-risk Neuroblastoma 96
Rapid and efficient nonviral gene delivery of CD154 to primary chronic lymphocytic leukemia cells 94
Mesenchymal stem/stromal cells: a new "cells as drugs" paradigm. Efficacy and critical aspects in cell therapy 88
New findings about the Interplay among Clarithromycin, Immune and Central Nervous Systems 82
null 78
LONG TERM EFFICACY OF HUMAN BONE MARROW MESENCHYMAL STEM CELLS IN TRAUMATIZED MICE BRAIN IS NOT AFFECTED BY IMMUNOSUPPRESSIVE TREATMENT. 73
LONG TERM EFFICACY OF HUMAN BONE MARROW MESENCHYMAL STEM CELLS IN TRAUMATIZED MICE BRAIN IS NOT AFFECTED BY IMMUNOSUPPRESSIVE TREATMENT. 63
Low-Dose Lenalidomide Improves CAR-Based Immunotherapy In CLL By Reverting T-Cell Defects In Vivo 43
Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia 30
Totale 15.132
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.519
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.217 0 0 0 271 293 376 422 196 281 131 182 65
2020/20212.003 120 164 292 204 139 138 166 124 153 223 85 195
2021/20221.376 51 135 208 106 71 68 58 66 138 134 98 243
2022/20232.370 271 739 198 224 136 355 24 151 171 6 69 26
2023/20241.359 46 39 61 56 202 348 264 62 112 8 30 131
2024/2025687 185 333 135 34 0 0 0 0 0 0 0 0
Totale 15.132